Multibagger FMCG Stock engaged in the manufacturing of specialty fats & butter and exotic products jumped 6 percent in the day’s trade following the commissioning of its new state-of-the-art fractionation plant to enhance the production of Cocoa Butter Equivalent (CBE) and specialty fats & butter .
With a market capitalization of Rs. 472 Crores, the shares of Manorama Industries Limited were trading at Rs. 472, up 5.84 percent from its previous day’s close price of Rs. 473.
Manorama Industries Limited has initiated the commissioning process at its new state-of-the-art fractionation plant, boasting a 25,000-tonnes per annum (TPA) capacity. This will lead to the Company’s total fractionation capacity to 40,000 TPA. This boost in capacity is expected to unlock growth in the Company’s top-line and bottom-line in the coming years.
It remains committed to meeting the growing demand by providing sustainable Cocoa Butter Equivalent (CBE), specialty fats, and butter amidst inflationary trends. The added capacity reinforces Manorama Industries’ stance in the global Cocoa Butter Equivalent (CBE) and specialty fats and butter industry.
Manorama Industries Limited is engaged in the manufacturing of specialty fats & butter, Cocoa Butter Equivalent, and exotic products from tree-borne and plant-based seeds and nuts. It has carved a niche in manufacturing Sal CBE & Stearin, Shea CBE & Stearin, Mango CBE & Stearin, and other exotic fats & butter. It offers customized solutions to Fortune 500 companies in the chocolate, confectionery, and cosmetic industry.
Its revenue from operations grew by 3.21 percent from Rs. 95.38 Crores in Q3FY23 to Rs. 98.45 Crores in Q3FY24, accompanied by profits of Rs. 7.16 Crore to Rs. 7.44 Crores.
It has reported a return on equity (ROE) of 10.5 percent and a return on capital employed (ROCE) of 13.2 percent, it is making decent returns on its equity and capital employed.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
